Clinical and public health implications of hiv-1 genetic diversity and drug resistance mutations in angola: A systematic review

Cruz S. Sebastião, Joana Morais, Miguel Brito

Research output: Contribution to journalReview articlepeer-review

Abstract

HIV-1 genetic diversity and drug resistance mutations (DRMs) remain a public health concern mainly in low-and middle-income countries. In this review, we estimated the HIV-1 molecular evolution over the past 40 years (1980-2019) in Angola to help guide affordable strategies for HIV-1 epidemic surveillance. We searched for studies written in English or Portuguese on HIV-1 diversity and DRMs carried out in Angola and published between 1980 and 2019. This review yielded eight studies describing a total of 493 samples. No HIV-1 Group N, O, and P were identified, whereas a ll n on-B s ubtypes f rom G roup M were i dentified. About 66% of HIV-1 subtypes were pure subtype and 34% recombinant strains. The frequency of recombi-nant strains increases from 1980 to 2019 (23.6%-41.4%, p<0.001). The subtypes C, F1, CRF02_AG, and the recombinant U/H were the most frequent. One DRM in the PIs was found (I54 M), 22 in the nucleoside reverse transcriptase inhibitors (NRTIs), and 18 in the non-nucleoside reverse transcriptase inhibitors (NNRTIs). The major DRM in the NRTIs was the M184V, whereas the G190A, K103N, and Y181C were the major DRMs in the NNRTIs. Over the past 40 years, the frequency of the DRM M184V (50-64.3%, p=0.363), G190A (17.2-46.2%, p=0.021), and K103N (34.5-42.3%, p=0.551) increased, while the frequency of Y181C (17.2-7.7%, p=0.289) decreased. The current review shows an increase in HIV-1 genetic complexity and DRMs in Angola. Our findings suggest the need to include PIs or integrase strand transfer inhibitors in the first-line antiretroviral therapy regimens in Angola. (AIDS Rev. (ahead of print)).

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalAids Reviews
Volume22
Issue number4
DOIs
Publication statusPublished - 2020

Keywords

  • Angola
  • Antiretroviral therapy failure
  • Drug resistance mutation
  • Genetic diversity
  • HIV-1

Fingerprint

Dive into the research topics of 'Clinical and public health implications of hiv-1 genetic diversity and drug resistance mutations in angola: A systematic review'. Together they form a unique fingerprint.

Cite this